Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783335 · ClinicalTrials.gov registry record
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
A clinical trial of Heart Failure and Heart Failure NYHA Class III, sponsored by Endotronix.
- Recruiting
- Registry status
- 2,150
- Enrollment target
- 1
- Study location
NCT06783335 is a study of Heart Failure and Heart Failure NYHA Class III that is actively recruiting participants, run by Endotronix. The registered enrollment target is 2,150 participants, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06783335, a study of Heart Failure and Heart Failure NYHA Class III, is actively recruiting participants, sponsored by Endotronix.
- RECRUITING
- Registry status
- 2,150 participants
- Enrollment target
- 1
- Study location
Study Summary
This retrospective, non-randomized cohort study will evaluate how well the Cordella PA Sensor System works compared to standard medication treatment in people with chronic heart failure. The study will track patients for two years to see if those using the Cordella system have fewer deaths and hospitalizations related to heart failure.
Conditions Studied
Interventions
- DEVICE Cordella PA Sensor System
- DRUG Standard of Care Pharmacologic Therapy
Study Locations (1)
Illinois
- Endotronix - Naperville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,150 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06783335
The ClinicalTrials.gov registry entry for NCT06783335 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,044-participant average among 397 other Heart Failure trials with a reported enrollment target. The listed sponsor is Endotronix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Cordella PA Sensor System is the first listed.
NCT06783335 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06783335 about?
NCT06783335 is a clinical study titled "Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure". This retrospective, non-randomized cohort study will evaluate how well the Cordella PA Sensor System works compared to standard medication treatment in people with chronic heart failure. The study will track patients for two years to see if those using the Cordella system have fewer deaths and hospi...
What is the current status of trial NCT06783335?
This trial is currently recruiting. The enrollment target is 2,150 participants. The study started on 2025-02-07. Estimated completion is 2030-12-31.
What conditions does trial NCT06783335 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure NYHA Class III.
What interventions are being tested in trial NCT06783335?
The interventions under investigation include: Cordella PA Sensor System (DEVICE), Standard of Care Pharmacologic Therapy (DRUG).
Who is sponsoring clinical trial NCT06783335?
This trial is sponsored by Endotronix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06783335 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.